04 May 2022 | News
China, Japan, and Korea are the top-most contributors to the breast cancer screening industry
According to the ResearchAndMarkets.com recent report, Asia Breast Cancer Screening Market is expected to reach $16.5 Billion by 2027 from $10.1 Billion in 2021 post recovery from the pandemic.
The major driving forces for expanding the breast cancer screening market in Asia are increasing breast cancer awareness, government and NGOs supporting breast cancer screening programs, and the aging population.
The mammogram is the leading method for breast cancer screening in Asian countries. Further, the report also made the market estimation that China, Japan, and Korea are the top three countries for breast cancer mammogram screening.
Other Asian countries included in the study are India, Singapore, Malaysia, and Thailand for breast cancer mammogram screening.
China, Japan, and Korea are the top-most contributors to the breast cancer screening industry. In addition, China holds significant dominance in the Asia breast cancer screening market. Further, a prominent women population and domestic NGOs initiatives support China to become a leader in the Asian breast cancer screening market.
The market players are considerably contributing to market growth by adopting various strategies, including new product launches, mergers and acquisitions, collaborations with the government, and technological advancements to stay competitive in the market.